ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)
South Korea · Delayed Price · Currency is KRW 14,610
+310 (2.17%)
At close: Dec 29, 2025
ImmuneOncia Therapeutics Revenue
ImmuneOncia Therapeutics had revenue of 715.75M KRW in the twelve months ending September 30, 2025. In the year 2024, ImmuneOncia Therapeutics had annual revenue of 654.54M with 495.04% growth.
Revenue (ttm)
715.75M
Revenue Growth
+495.04%
P/S Ratio
1,513.87
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.08T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 654.54M | 544.54M | 495.04% |
| Dec 31, 2023 | 110.00M | -7.62B | -98.58% |
| Dec 31, 2022 | 7.73B | 7.70B | 21,413.30% |
| Dec 31, 2021 | 35.95M | 33.45M | 1,337.90% |
| Dec 31, 2020 | 2.50M | 1.00M | 66.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| Hyundai Motor Company | 186.04T |
| Kia Corporation | 113.20T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Hanwha Aerospace | 23.11T |
| Doosan Enerbility | 16.79T |
| HD Hyundai Heavy Industries | 16.39T |